Solberg Leif I, Crain A Lauren, Sperl-Hillen JoAnn M, Hroscikoski Mary C, Engebretson Karen I, O'Connor Patrick J
HealthPartners Research Foundation, Minneapolis, Minn 55440-1524, USA.
Ann Fam Med. 2006 Jan-Feb;4(1):69-74. doi: 10.1370/afm.426.
We wanted to determine whether a major improvement in access to primary care during 2000 was associated with changes in the quality of care for patients with depression.
Health plan administrative data were analyzed by multilevel regression to compare the quality of care received by patients with depression between 1999 and 2001, a time without major changes in depression care guidelines. Approximately 6,000 patients with depression who received all care in a large multispecialty medical group during any single year were subjects for this study. Thirteen different quality measures assessed process quality under the dimensions of effectiveness, timeliness, safety, and patient-centeredness.
The largest change was a reduction in the proportion of depressed patients with no follow-up visit in primary care after starting a new antidepressant medication: from 33.0% before a change in access to care to 15.4% afterward, P =.001. During the same period, continuity of care in primary care improved (>50% of primary care visits to 1 doctor increased from 67.3% to 74.0%, P = or <.001), as did persistence of 6-month antidepressant medication (from 46.2% to 50.8%, P = or <.001). Further analyses found that the latter change was primarily associated with the change in continuity of care. Measures of subspecialty mental health care worsened during this time.
Marked improvement in access to primary care for 1 year was associated with some improvement in primary care for patients with depression, but the mechanism appeared to be improved continuity. Those planning to implement advanced access to care need to do so in such a way that continuity of care is enhanced rather than harmed by the change.
我们想确定2000年初级保健可及性的重大改善是否与抑郁症患者的护理质量变化相关。
通过多水平回归分析健康计划管理数据,以比较1999年至2001年抑郁症患者接受的护理质量,这一时期抑郁症护理指南没有重大变化。本研究的对象是在任何一年中在一个大型多专科医疗集团接受所有护理的约6000名抑郁症患者。13项不同的质量指标在有效性、及时性、安全性和以患者为中心等维度下评估过程质量。
最大的变化是开始使用新的抗抑郁药物后,初级保健中无后续随访的抑郁症患者比例下降:从护理可及性改变前的33.0%降至之后的15.4%,P = 0.001。同期,初级保健中的护理连续性得到改善(看同一位医生的初级保健就诊比例>50%从67.3%增至74.0%,P = 或 < 0.001),6个月抗抑郁药物治疗的持续性也得到改善(从46.2%增至50.8%,P = 或 < 0.001)。进一步分析发现,后一变化主要与护理连续性的改变相关。在此期间,专科心理健康护理指标恶化。
初级保健可及性在1年内的显著改善与抑郁症患者的初级保健有一定改善相关,但机制似乎是护理连续性的改善。那些计划实施高级护理可及性的人需要以这样一种方式进行,即护理连续性得到增强而非因这种改变而受到损害。